Generic drug Encouraged list-2nd batch

On:
In: Medicine/medical devices
On December 30, the National Health Commission issued the list of the second batch of drugs to encourage imitation. The list was selected and demonstrated by the National Health Commission in conjunction with other ministries for drugs whose patents are about to expire from 2021 to 2022, including drugs for COPD and asthma. China encourages the imitation of drugs for the prevention and treatment of major infectious diseases and rare diseases, drugs for the disposal of public health emergencies, drugs for children’s use, and drugs for which no registration application has been filed one year before the expiration of theRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is ＄5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114

Existing Users Log In
   
New User Registration
*Required field

Related posts:

  1. Measures for the administration of drug registration 2020
  2. National Drugs Catalogue of Basic Medical, labor Injury and Maternity Insurance
  3. Implementation of Drug Administration Law
  4. Quality management specification for drug clinical trials
  5. Measures on advertisement of drug, Healthy food and medical device
  6. Drug Administration Law
  7. Measures for the Administration of Drug Recall
  8. Catalogue of encouraged industries for foreign investment 2020
  9. Clinical trial for new drug registration in China 2021
  10. Negative list for market access 2020